Leukocyte migration in experimental inflammatory bowel disease

Mediators of Inflammation

Volumn 6, Issue 2, 1997, Pages 85-93

  Van Rees, E P ^a   Palmen, M J H J ^a   Van De Goot, F R W ^a   Macher, B A ^b   Dieleman, L A ^c  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b SAN FRANCISCO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Chemokines; Inflammatory bowel disease; Integrins; Selectins

Indexed keywords

ALCOHOL; CELL ADHESION MOLECULE; CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; RANTES; SELECTIN; SYNTHETIC PEPTIDE; TRINITROBENZENESULFONIC ACID;

ANIMAL MODEL; CHRONIC INFLAMMATION; CROHN DISEASE; DENDRITIC CELL; ENDOTHELIUM CELL; ENTERITIS; HISTOPATHOLOGY; HUMAN; LEUKOCYTE MIGRATION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ANIMALIA;

EID: 0030994576     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359791776     Document Type: Review

References (60)

1. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
3. Palmen MJHJ, Dieleman LA, van der Ende MB, Uyterlinde A, Peña AS, Meuwissen SGM, van Rees EP. Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis. Clin Exp Immunol 1995; 99: 226-232.
4. Yamada T, Marshall S, Specian RD, Grisham M. A comparative analysis of two models of colitis in rats. Gastroenterology 1992; 102: 1524-1534.
5. Wilders MM, Drexhage HA, Kokje M, Verspaget HW, Meuwissen SGM. Veiled cells in chronic idiopathic inflammatory bowel disease. Clin Exp Immunol 1984; 55: 461-468.
6. Seldenrijk CA, Drexhage HA, Meuwissen SGM, Pals ST, Meijer CJ. Dendritic cells and scavenger macrophages in inflammatory bowel disease. Gut 1989; 30: 484-491.
7. Alison MC, Poulter LW. Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease. Clin Exp Immunol 1991; 85: 504-509.
8. Selby WS, Poulter LW, Hobbs S, Jewell DP, Janossy G. Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Path 1983; 36: 379-384.
9. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533-539.
10. Sartor RB, Bender DE, Allen JB, et al. Chronic experimental entercolitis and extra-intestinal inflammation are T lymphocyte dependent. Gastroenterology 1993; 104: A775.
11. Lawrence MB, Springer TA, Leukocytes roll on a selectin at physiologic flow rates: distinct from and prerequisite for adhesion through integrins. Cell 1991; 65: 859-873.
12. Ushiyama S, Laue TM, Moore KL, Erickson HP, McEver RP. Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. J. Biol Chem 1993; 268: 15229-15237.
13. Bargatze RF, Kurk S, Butcher EC, Jutila MA. Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J Exp Med 1994; 180: 1785-1790.
14. Jutila MA, Kurk S. Analysis of bovine γδ T cell interactions with E-, P-, and L-selectin. J Immunol 1996; 156: 289-296.
15. Schurmann GM, Bishop AH, Facer P, Vecchio M, Lee JC, Rampton DS, et al. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut 1995; 36: 411-418.
16. Pooley N, Ghosh L, Sharon P. Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis. Dig Dis Sci 1995; 40: 219-225.
17. Jones SC, Banks RE, Gearing AJ, Hemingway IK, Ibbotson SH, Dixon MF, Axon AT. Adhesion molecules in inflammatory bowel disease. Gut 1995; 36: 724-730.
18. 2+ ions. J Biol Chem 1992; 267: 19846-19853.
19. Briggs JB, Oda Y, Gilbert JH, Schaefer ME, Macher BA. Peptides inhibit selectin-mediated cell adhesion in vitro, and neutrophil influx into inflammatory sites in vivo. Glycobiology 1995; 5: 583-588.
20. Van Rees EP, Van der Goot FRW, Palmen MJHJ, Macher BA. Peptide inhibitor of selectin-mediated cell adhesion has a beneficial effect in experimental IBD. Gastroenterology 1996; 110: A1036.
21. Briggs JB, Larsen RA, Harris RB, Sekar KVS, Macher BA. Structure/ activity studies of anti-inflammatory peptides based on a conserved peptide region of the lectin domain of E-, L- and P-selectin. Glycobiology 1996; 6: 831-836.
22. Lindley IJD, Westwick J, Kunkel SL. Nomenclature announcement: the chemokines. Immunol Today 1993; 14: 24.
23. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercine' cytokine family. Annu Rev Immunol 1991; 9: 617-648.
24. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992; 12: 17-46.
25. Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroent 1992; 87: 1447-1452.
26. Mitsuyama K, Toyonaga A, Sasaki E, et al. IL-8 as an important chemoaltractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994; 96: 432-436.
27. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, Mueller C. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Path 1994; 144: 997-1007.
28. Grimm MC, Elsbury SK, Pavli P, Doe WF. Interleukin 1: cells of origin in inflammatory bowel disease. But 1996; 38: 90-98.
29. Jones SC, Evans SW, Lobo AJ, Ceska M, Axon AT, Whicher JT. Sum interleukin-8 in inflammatory bowel disease. J Gastroenterol Hepatol 1993; 8: 508-512.
30. Reinecker HC, Loh EY, Ringler DJ, Mehta A, Rombeau JL. McDermott RP. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995; 108: 40-50.
31. Mazzucchelli L, Hauser C, Zgraggen K, Wagner HE, Hess MW, Laissue JA, Mueller C. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J Pathology 1996; 178: 201-206.
32. Grimm MC, Elsbury SK, Pavli P, Doe WF. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukocyte Biol 1996; 59: 804-812.
33. Berlin C, Berg EL, Briskin MJ, et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1-1. Cell 1993; 74: 185-195.
34. Nakamura S, Ohtani H, Watanabe Y, et al. In situ expression of the cell adhesion molecules in inflammatory bowel disease: evidence of immunologic activation of vascular endothelial cells. Lab Invest 1993; 89: 77-85.
35. Jones SC, Banks RE, Haider A, et al. Adhesion molecules in inflammatory bowel disease. Gut 1995; 36: 724-730.
36. Patel RT, Pall AA, Adu D, Keighley MR. Circulating soluble adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 1037-1041.
37. Wong PY, Yue G, Yin K, Miyasaka M, Lane CL, Manning AM, Anderson DC, Sun FF. Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease. J Pharmacol Exp Ther 1995; 274: 475-480.
38. Horgan MJ, Wright DS, Malik AB. Antibody against leukocyte integrin (CD 18) prevents reperfusion-induced lung vascular injury. Am J Physiol 1990; 259: 1315-1319.
39. Vedder NB, Winn RK, Rice CL, Chi EY, Arfors KE, Harlan JM. Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc Natl Acad Sci 1990; 87: 2643-2646.
40. Mileski WJ, Winn RK, Vedder NB, Pohlman TH, Harlan JM, Rice CL. Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 1990; 108: 206-212.
41. Wallace JL, Arlbrs KE, McKnight GW. A monoclonal antibody against the CD 18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 1991; 100: 878-883.
42. Wallace JL, Higa A, McKnight GW, MacIntyre DE. Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence. Inflammation 1992; 16: 343-354.
43. Palmen MJHJ, Dijkstra CD, van der Ende MB, Peña AS, van Rees EP. Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clin Exp Immunol 1995; 101: 351-356.
44. Selve N, Wohrmann T. Intestinal Inflammation in TNBS sensitized rats as a model of chronic inflammatory bowel disease. Med Inflamm 1992; 1: 121-126.
45. Beck FL, Moris GF, Wade AW, Szewczuk M, Wallace JL. Immunological manipulation of disease progression in a rat model of chronic inflammatory bowel disease of the colon. In: McDermott R, ed. Inflammatory Bowel Disease: Current Status and Future Approach. Amsterdam: Elsevier Science Publishers, 1988: 201-206.
46. Neurath MF, Fuss I, Kelsall BL, Stuber E, Stroher W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182: 1281-1290.
47. Mullin GE, Vezza FR, Sampat A, et al. Abnormal IL-10 mRNA production in the intestinal mucosal lesions in inflammatory bowel disease. Gastroenterology 1993; 104: A751.
48. Appleyard C, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 1995; 269: 119-125
49. Palmen MJHJ, Wijburg OLC, Kroes H, Peña AS, Van Rees EP. Hapten-induced experimental colitis is transferable by extra-intestinal CD4+ T cells. (Submitted).
50. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347:669-671.
51. Berg RS. Bacterial translocation from the gastrointestinal tract. Trends Microbiol 1995; 3: 149-154.
52. Berg RD, Wommack E, Deitch EA. Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Arch Surg 1988; 123: 1359-1364.
53. Alon R, Rossiter H, Wang X, Springer TA, Kupper TS. Distinct cell surface ligands mediate T lymphocyte attachment and rolling on P- and E-selectin under physiological low. J Cell Biol 1994; 127: 1485-1495.
54. Jones DA, McIntire LV, Smith CW, Picker LJ. A two-step adhesion cascade for T cell/endothelial cell interactions under flow conditions. J Clin Invest 1994; 94: 2443-2450.
55. Jutila MA, Bargatze RF, Kurk S, Warnock RA, Ehsani N, Watson SR, Walchek B. Cell surface P- and E-selectin support shear-dependent rolling of bovine γδ T cells. J Immunol 1994; 153: 3917-3928.
56. Butcher EC, Scollay RG, Weissman IL. Organ specificity of lymphocyte homing: mediation by highly selectively lymphocyte interaction with organ-specific determinants on high endothelial venules. Eur J Immunol 1980; 10: 556-561.
57. Jalkanen S, Steere AC, Fox RI, Butcher EC. A distinct endothelial recognition system that controls lymphocyte traffic into inflamed synovium. Science 1986; 233: 556-560.
58. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991; 349: 796-799.
59. Yacyshyn BR, Lazarovits A, Tsai V, Matejko K. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar pattern. Gastroenterology 1994; 107: 1364-1371.
60. Salmi M, Granfors K, MacDermott R, Jalkanen S. Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases. Gastroentemlogy 1994; 106: 596-605.